Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. - Wikidata - awgldk - TriplyDB

Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.

Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.

http://www.wikidata.org/entity/Q34125003

about

An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients.Tissue microarray construction for salivary gland tumors study.Trastuzumab for the treatment of salivary duct carcinoma.Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma.Recurrent salivary gland cancer.Salivary duct carcinoma: what is already known, and can we improve survival?Salivary gland carcinomas.Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.Management of salivary gland tumors.What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma.Update on lacrimal gland neoplasms: Molecular pathology of interest HER2 expression status in diverse cancers: review of results from 37,992 patients.Genetic alterations in salivary gland cancers.A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases.Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays.Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib.Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.Predictors of cervical lymph node metastasis in salivary gland cancer.Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice.An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.Phase II study of gefitinib in patients with advanced salivary gland cancers.Management and outcome of salivary duct carcinoma in major salivary glands.Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumab.

P2860

Q33619720-29196F3C-FF9D-4A6B-9A74-A1AA92AEB83E Q34436470-FD1994AE-4D8B-41B1-AA38-741B9CF11CA6 Q35333614-31EF4692-3CD6-48A3-91B7-0B615729B246 Q35764742-0BB21780-AADC-4496-856E-736073577DD6 Q35879834-C35C7F65-2909-4FE8-BC2E-16F53A6E8196 Q36544198-F6B5D334-D25B-4DE6-B567-880814BC4A2E Q36714388-A9F96861-68B6-48F4-9BC0-C260B62FF769 Q36874710-F7DE9E3E-953C-4E0A-8979-053674FD2C97 Q36888316-85922873-0F95-40B4-A85B-FC7119DC4390 Q37013995-F1690A6A-8107-4917-B2F9-E75119E9B95C Q37015111-A47D3A22-763B-4398-9735-77EBB45ACD64 Q37154089-7A4DEEA6-7498-4B10-A248-2844EA9DE2A9 Q37295302-E0684CD6-471D-4BFE-A98F-95DAC6F31BCE Q37973008-096EFA74-FA4F-433E-A122-0D01664E1C4A Q38001863-5668098A-B8B4-410B-8C11-EF457AF3C0DF Q38030395-C1A960C9-CB51-4630-9CE1-5C585D5B5C31 Q38033677-A923FDED-05F5-4F8E-8B08-6274153806CE Q38055494-CC56B7F9-BAE5-4FD1-A037-2ECC0D90E26A Q38086436-38610951-68A8-4E15-A9B3-E1CE98B4948F Q38130248-3C24C0F1-92B7-4343-AE93-67F3F5E1990C Q38364900-0791C4CF-F103-413E-9991-B8B2AF940947 Q38755879-25B2118E-F127-422F-A71E-7660E43E6542 Q38841254-6EB63A9E-9813-4564-829F-0BF0A1213B93 Q39491094-8E44624A-C1C9-46A8-A65A-9D08E44022CF Q39503071-F20B0E50-50E4-48DE-8310-D5E1F1354E89 Q40452694-3D182993-99E6-47AB-A129-3898809EF251 Q40657619-DADD5121-7F6C-4B91-B9AF-FE0580CA52C1 Q40886552-AA40D24A-9E0D-4A76-BB01-0FDAEFE10EA9 Q41601105-246B73C9-0441-42F7-ADC7-1213EF8B0A79 Q41708696-C79C00C3-2B5B-48E3-9E15-E87A9B8EFBB5 Q42233857-7F63CF85-9F47-4844-A607-7165F66967D5 Q43529428-49853F94-1DF8-4A24-9DDF-BF08FDB7D0BF Q43635123-698DAB2E-24F0-4EBD-AE39-D7965EFFACCC Q45716219-774FDD3F-CA13-44C6-8D28-F921CE2A7A4E Q46241018-1120F294-85E5-48AA-B739-B7F504C26B31 Q46447217-E1D8385C-3401-481E-A2DB-43FDEE5F5208 Q47859326-DA2409E4-EB6E-4780-B3D3-D96239F921FB Q48123633-17BF2CE1-4E59-4E0C-A19D-A2C4822996E8 Q49511046-471B4CED-AFB5-4EEC-BAAE-A510D0454D57 Q51127479-842EF974-0622-43C5-A87E-4D3E6E424E49

P2860

Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.

http://www.wikidata.org/entity/Q34125003

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Genetic and expression analysi ...... and therapeutic significance.

@ast

Genetic and expression analysi ...... and therapeutic significance.

@en

Genetic and expression analysi ...... and therapeutic significance.

@nl

type

label

Genetic and expression analysi ...... and therapeutic significance.

@ast

Genetic and expression analysi ...... and therapeutic significance.

@en

Genetic and expression analysi ...... and therapeutic significance.

@nl

prefLabel

Genetic and expression analysi ...... and therapeutic significance.

@ast

Genetic and expression analysi ...... and therapeutic significance.

@en

Genetic and expression analysi ...... and therapeutic significance.

@nl

P1433

Q34125003-D03D8C98-017B-4637-AA00-EF18D4490F95

P1476

Q34125003-34A2D82C-725D-4394-AF35-FA97C23DFEF9

P2093

Q34125003-852CE958-1BB9-429D-99F8-6EC1E62F591E

Q34125003-925B6519-EF21-4D9F-828A-F1DA21C91E86

Q34125003-92DCEED8-A6B7-4A97-ABD5-06A817271A39

Q34125003-A26D5A50-F2E9-47D4-ABFF-34C8CA895790

Q34125003-BBD05940-B4E3-4721-9839-4ED91E002C71

P2860

Q34125003-0424AA08-E905-4070-8466-41EF99682B9C

Q34125003-09674552-C799-4B4C-9941-779102D27FC9

Q34125003-150F5398-46F4-4278-8584-21873803B47D

Q34125003-18C45AAF-ABEA-4CAB-8564-D2A1ED7DA261

Q34125003-1AECE64A-2E8F-43C2-9239-DA312DEDA776

Q34125003-230D0C61-C239-41AF-8B58-3929C7E64F71

Q34125003-3799F221-D952-49ED-85F0-DA84253190D8

Q34125003-3F89C085-524C-4565-AF9C-45593FC1DBD5

Q34125003-403286BF-501A-49BD-A21F-846415AC6D34

Q34125003-49DA0DBA-339B-4733-A9DD-22589ED8514B

P304

Q34125003-0F6910D2-955B-4398-860F-2FEC020080F5

P31

Q34125003-F27B0469-EC1C-4EE5-BFAA-452E065EDE6D

P356

Q34125003-636EB885-5282-40FA-AF08-62B7ED9B62A5

P407

Q34125003-D657FF48-3E5C-4EBA-AF36-5207A93C8DE4

P433

Q34125003-857BC2FE-5AD5-4DAC-B8E8-2CE127CBAC46

P478

Q34125003-B1165C25-EC97-4775-B94B-5537B2F384EE

P50

Q34125003-DBECE990-47BA-4E8B-BC22-2FA45EE29853

P577

Q34125003-121F9082-BBD9-4476-8A46-0828E04F934D

P698

Q34125003-24D31CE8-3044-41CF-89D2-142B7F1895A4

P932

Q34125003-B785F1CC-9D9F-49EA-91C1-0F40110ABC99

P356

1078-0432.CCR-09-0238

P1433

Clinical Cancer Research

P1476

Genetic and expression analysi ...... and therapeutic significance.

@en

P2093

Adel K El-Naggar

http://www.w3.org/2001/XMLSchema#string

Dianna B Roberts

http://www.w3.org/2001/XMLSchema#string

Li Mao

http://www.w3.org/2001/XMLSchema#string

Merrill S Kies

http://www.w3.org/2001/XMLSchema#string

Randal S Weber

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation.

HER-2/neu (c-erb-B2) gene and protein in breast cancer.

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

P304

2266-2274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-0238

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Michelle D Williams

P577

2010-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20371674

http://www.w3.org/2001/XMLSchema#string

P932

4152860

http://www.w3.org/2001/XMLSchema#string